Cargando…

Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report

Few data are available regarding the effectiveness of anti-SARS-CoV-2 vaccine in immunocompromised patients. Vaccination may have a suboptimal efficacy in this population, in particular if patients are exposed to anti-B-cell therapy. We report the virological and clinical characteristics of a patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calò, Federica, Onorato, Lorenzo, Pisaturo, Mariantonietta, Pinto, Antonio, Alessio, Loredana, Monari, Caterina, Minichini, Carmine, Arcamone, Manuela, Di Fraia, Alessandra, Atripaldi, Luigi, Tiberio, Claudia, Coppola, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323164/ https://www.ncbi.nlm.nih.gov/pubmed/35891185 http://dx.doi.org/10.3390/vaccines10071021

Ejemplares similares

Virological Factors Associated with Failure to the Latest Generation of Direct Acting Agents (DAA) and Re-Treatment Strategy: A Narrative Review
por: Onorato, Lorenzo, et al.
Publicado: (2021)

Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study
por: Pisaturo, Mariantonietta, et al.
Publicado: (2022)

Correction: Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study
por: Pisaturo, Mariantonietta, et al.
Publicado: (2023)

Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease †
por: Alessio, Loredana, et al.
Publicado: (2022)

Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma
por: Pisaturo, Mariantonietta, et al.
Publicado: (2021)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
por: Pisaturo, Mariantonietta, et al.
Publicado: (2019)

Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features
por: Coppola, Nicola, et al.
Publicado: (2017)

Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis
por: Mariantonietta, Pisaturo, et al.
Publicado: (2019)

Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Onorato, Lorenzo, et al.
Publicado: (2021)

Epidemiology and management of hepatitis C virus infections in immigrant populations
por: Coppola, Nicola, et al.
Publicado: (2019)

Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy
por: Alessio, Loredana, et al.
Publicado: (2018)

Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2
por: Russo, Antonio, et al.
Publicado: (2020)

Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
por: Sagnelli, Caterina, et al.
Publicado: (2019)

Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review
por: Russo, Antonio, et al.
Publicado: (2020)

Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn
por: Monari, Caterina, et al.
Publicado: (2022)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
por: Sagnelli, Evangelista, et al.
Publicado: (2012)

P1103: OBINUTUZUMAB INDUCTION AND MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINAEMIA
por: Wróbel, Tomasz, et al.
Publicado: (2023)

Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV Infection
por: Coppola, Nicola, et al.
Publicado: (2018)

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia
por: Evans, Sarah S., et al.
Publicado: (2015)

Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia
por: Sachdeva, Mamta, et al.
Publicado: (2015)

Early predictors of clinical deterioration in a cohort of outpatients with COVID‐19 in southern Italy: A multicenter observational study
por: Monari, Caterina, et al.
Publicado: (2022)

COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study
por: Coppola, Nicola, et al.
Publicado: (2016)

Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
por: Coppola, Nicola, et al.
Publicado: (2014)

Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study
por: Pisaturo, Mariantonietta, et al.
Publicado: (2021)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure–Response in CLL
por: Gibiansky, E, et al.
Publicado: (2014)

Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review
por: Onorato, Lorenzo, et al.
Publicado: (2022)

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
por: Herold, Michael, et al.
Publicado: (2022)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
por: Messina, Vincenzo, et al.
Publicado: (2020)

Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
por: Coppola, Nicola, et al.
Publicado: (2012)

Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Impact of an Education-Based Antimicrobial Stewardship Program on the Appropriateness of Antibiotic Prescribing: Results of a Multicenter Observational Study
por: Calò, Federica, et al.
Publicado: (2021)

The Impact of the SARS-Cov2 Pandemic on a Persuasive Educational Antimicrobial Stewardship Program in a University Hospital in Southern Italy: A Pre-Post Study
por: Macera, Margherita, et al.
Publicado: (2021)

Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study
por: Macera, Margherita, et al.
Publicado: (2021)

Disseminated Enteroviral Infection Associated with Obinutuzumab
por: Dendle, Claire, et al.
Publicado: (2015)

Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861
por: Panjideh, Hossein, et al.
Publicado: (2022)

HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
por: Piermatteo, Lorenzo, et al.
Publicado: (2021)

Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19—An Observational Retrospective Study
por: Russo, Antonio, et al.
Publicado: (2023)

Correction Notice: Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m7gkfgplhg9nt8qt8i30eb6t7m